Involvement of 15-lipoxygenase in early stages of atherogenesis - PubMed (original) (raw)
Involvement of 15-lipoxygenase in early stages of atherogenesis
H Kühn et al. J Exp Med. 1994.
Abstract
The arachidonate 15-lipoxygenase which is expressed in atherosclerotic lesions is implicated in the oxidative modification of low density lipoproteins during atherogenesis. To obtain experimental in vivo evidence for this hypothesis, we analyzed the structure of oxygenated lipids isolated from the aorta of rabbits fed with a cholesterol-rich diet for different time periods and compared the pattern of oxygenation products with that isolated from low density lipoproteins treated in vitro with the pure rabbit 15-lipoxygenase and with oxygenated lipids isolated from advanced human atherosclerotic lesions. In early atherosclerotic lesions (12-wk cholesterol feeding), specific lipoxygenase products were detected whose structure was similar to those isolated from lipoxygenase-treated low density lipoproteins. The appearance of these products did coincide with the lipid deposition in the vessel wall. In later stages of atherogenesis (26-wk cholesterol feeding) the degree of oxidative modification of the tissue lipids did increase but the share of specific lipoxygenase products was significantly lower, suggesting an increasing overlay of the specific lipoxygenase products by nonenzymatic lipid peroxidation. In advanced human atherosclerotic lesions, large amounts of oxygenation products were detected whose structure suggests a nonenzymatic origin. These data suggest that the arachidonate 15-lipoxygenase is of pathophysiological importance during the early stages of atherogenesis. In later stages of plaque development nonenzymatic lipid peroxidation becomes more relevant.
Similar articles
- In vivo action of 15-lipoxygenase in early stages of human atherogenesis.
Kühn H, Heydeck D, Hugou I, Gniwotta C. Kühn H, et al. J Clin Invest. 1997 Mar 1;99(5):888-93. doi: 10.1172/JCI119253. J Clin Invest. 1997. PMID: 9062346 Free PMC article. - Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development.
Shen J, Herderick E, Cornhill JF, Zsigmond E, Kim HS, Kühn H, Guevara NV, Chan L. Shen J, et al. J Clin Invest. 1996 Nov 15;98(10):2201-8. doi: 10.1172/JCI119029. J Clin Invest. 1996. PMID: 8941635 Free PMC article. - 12/15-lipoxygenase, oxidative modification of LDL and atherogenesis.
Funk CD, Cyrus T. Funk CD, et al. Trends Cardiovasc Med. 2001 Apr-May;11(3-4):116-24. doi: 10.1016/s1050-1738(01)00096-2. Trends Cardiovasc Med. 2001. PMID: 11686000 Review. - Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques.
Folcik VA, Nivar-Aristy RA, Krajewski LP, Cathcart MK. Folcik VA, et al. J Clin Invest. 1995 Jul;96(1):504-10. doi: 10.1172/JCI118062. J Clin Invest. 1995. PMID: 7615823 Free PMC article. - Lipoxygenases and atherosclerosis: protection versus pathogenesis.
Cathcart MK, Folcik VA. Cathcart MK, et al. Free Radic Biol Med. 2000 Jun 15;28(12):1726-34. doi: 10.1016/s0891-5849(00)00230-6. Free Radic Biol Med. 2000. PMID: 10946214 Review.
Cited by
- Irradiation of the kidneys causes pathologic remodeling in the nontargeted heart: A role for the immune system.
Lenarczyk M, Laiakis EC, Mattson DL, Johnson BD, Kronenberg A, North PE, Komorowski R, Mäder M, Baker JE. Lenarczyk M, et al. FASEB Bioadv. 2020 Oct 23;2(12):705-719. doi: 10.1096/fba.2020-00071. eCollection 2020 Dec. FASEB Bioadv. 2020. PMID: 33336158 Free PMC article. - 15-Lipoxygenase-1 biosynthesis of 7S,14S-diHDHA implicates 15-lipoxygenase-2 in biosynthesis of resolvin D5.
Perry SC, Kalyanaraman C, Tourdot BE, Conrad WS, Akinkugbe O, Freedman JC, Holinstat M, Jacobson MP, Holman TR. Perry SC, et al. J Lipid Res. 2020 Jul;61(7):1087-1103. doi: 10.1194/jlr.RA120000777. Epub 2020 May 13. J Lipid Res. 2020. PMID: 32404334 Free PMC article. - Atherosclerosis: integration of its pathogenesis as a self-perpetuating propagating inflammation: a review.
Poston RN. Poston RN. Cardiovasc Endocrinol Metab. 2019 Jun;8(2):51-61. doi: 10.1097/XCE.0000000000000172. Epub 2019 May 15. Cardiovasc Endocrinol Metab. 2019. PMID: 31588428 Free PMC article. Review. - Regulation and Functions of 15-Lipoxygenases in Human Macrophages.
Snodgrass RG, Brüne B. Snodgrass RG, et al. Front Pharmacol. 2019 Jul 4;10:719. doi: 10.3389/fphar.2019.00719. eCollection 2019. Front Pharmacol. 2019. PMID: 31333453 Free PMC article. Review. - Emerging cellular functions of the lipid metabolizing enzyme 15-Lipoxygenase-1.
Çolakoğlu M, Tunçer S, Banerjee S. Çolakoğlu M, et al. Cell Prolif. 2018 Oct;51(5):e12472. doi: 10.1111/cpr.12472. Epub 2018 Jul 30. Cell Prolif. 2018. PMID: 30062726 Free PMC article. Review.
References
- N Engl J Med. 1986 Feb 20;314(8):488-500 - PubMed
- Biochim Biophys Acta. 1985 Mar 29;839(1):62-70 - PubMed
- Virchows Arch A Pathol Anat Histopathol. 1986;410(3):231-8 - PubMed
- Proc Natl Acad Sci U S A. 1987 Aug;84(16):5928-31 - PubMed
- Proc Natl Acad Sci U S A. 1987 Nov;84(21):7725-9 - PubMed